Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eiger BioPharmaceuticals Inc (NASDAQ:EIGR)

16.00
Delayed Data
As of Jan 12
 +0.65 / +4.23%
Today’s Change
6.10
Today|||52-Week Range
16.20
+14.70%
Year-to-Date

Today’s Trading

Previous close15.35
Today’s open15.20
Day’s range15.20 - 16.20
Volume205,550
Average volume (3 months)72,298
Market cap$168.3M
Data as of 4:00pm ET, 01/12/2018

Growth & Valuation

Earnings growth (last year)+71.93%
Earnings growth (this year)+39.92%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.28

Competitors

 Today’s
change
Today’s
% change
NBYNovaBay Pharmaceutic...+0.10+2.78%
SPHSSophiris Bio Inc+0.01+0.44%
RNNRexahn Pharmaceutica...-0.02-0.93%
LIFEaTyr Pharma Inc-0.05-1.27%
Data as of 8:00pm ET, 01/12/2018

Financials

Next reporting dateMarch 22, 2018
EPS forecast (this quarter)-$1.06
Annual revenue (last year)$0.00
Annual profit (last year)-$47.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David A. Cory
COO, Director &
Executive Medical Officer
David Apelian
Corporate headquarters
Palo Alto, California

Forecasts